Articles Tagged With:
-
Lawmakers Broker Agreement to End Surprise Billing
Bipartisan compromise was included in latest COVID-19 relief package.
-
Recommendation: Less Major Surgery for Heart Valve Disease
Advancing technology creates opportunities for safer solutions, according to guideline authors.
-
DSMBs Have Helped Advance Safe, Effective HIV/AIDS Research
Data safety monitoring boards (DSMBs) have played a big role in helping the most effective and safe HIV therapies advance.
-
Data Safety Monitoring Boards Were Quietly Behind the Scenes, but No More
DSMBs have been an essential fabric of clinical trials in recent decades, but until 2020, their work largely was under the public radar.
-
OHRP Looks Back at its First 20 Years
IRB Advisor asked OHRP to look back since its launch in June 2000 to see how human research protections has evolved.
-
20 Years of Reports on Research Protection
To commemorate the past 20 years of human research protection, as well as two decades of IRB Advisor, we asked editorial advisory board members to comment on how things have changed since 2001.
-
COVID-19 Trial Protocol/Consent Issues Discussed on National Stage
Placebo vs. access to the available vaccine
-
USPSTF: Screen At-Risk Adolescents, Adults for Hepatitis B
Advocacy group says recommendations are too narrow.
-
Slamming Forward
-
Diagnosis and Management of Supraventricular Tachycardia
Supraventricular tachycardia (SVT) usually presents to the emergency department as a result of a combination of symptoms, including palpitations, dyspnea, and chest pain. Less frequent symptoms include lightheadedness, near-syncope, or syncope due to reduced cerebral perfusion. Accurate diagnosis of SVT guides acute treatment. Although many doctors are good at pattern recognition on electrocardiograms (ECGs), having a methodical approach to think through SVT is extremely helpful.